Crescendo Biologics

Crescendo Biologics

Signal active

Organization

Contact Information

Overview

Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.

The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments that retain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.

About

Industries

Biotechnology, Health Care, Therapeutics

Founded

2007

Employees

51-100

Headquarters locations

Europe

Social

N/A

Profile Resume

Crescendo Biologics headquartered in Europe, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $14.2B in funding across 96 round(s). With a team of 51-100 employees, Crescendo Biologics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Crescendo Biologics, raised $7.3M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Joyce Young

Joyce Young

Head of Transgenic Platforms

imagePlace Theo Harold

Theo Harold

CFO

imagePlace Pavel Pisa

Pavel Pisa

CMO

imagePlace Philip Bland-Ward

Philip Bland-Ward

Chief Development Officer (CDO)

Funding Rounds

Funding rounds

8

Investors

4

Lead Investors

0

Total Funding Amount

$148.2M

Details

5

Crescendo Biologics has raised a total of $148.2M in funding over 5 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2018Early Stage Venture70.0M
2014Early Stage Venture3.3M
2013Early Stage Venture28.5M
2010Early Stage Venture7.3M

Investors

Crescendo Biologics is funded by 29 investors.

Investor NameLead InvestorFunding RoundPartners
Crescendo Biologics-FUNDING ROUND - Crescendo Biologics32.0M
Andera Partners-FUNDING ROUND - Andera Partners32.0M
Crescendo Biologics-FUNDING ROUND - Crescendo Biologics7.3M
Future Planet Capital-FUNDING ROUND - Future Planet Capital7.3M

Recent Activity

There is no recent news or activity for this profile.